|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.70 EUR | -0.05% |
|
-0.28% | +16.97% |
| 12-04 | Grifols achieves self-sufficiency in plasma-derived medicines in Egypt | RE |
| 12-03 | European Equities Traded in the US as American Depositary Receipts Higher in Wednesday Trading | MT |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 17.02x | 1.14x | 0.1x | 2.06x | 8.52x | 11.34x | 1.33% | 7.66B | ||
| 17.77x | 2.33x | 2.71x | 4.78x | 12.53x | 14.46x | 0.51% | 76.62B | ||
| 22.92x | 2.79x | -1.56x | 4.18x | 12.15x | 14.02x | 2.56% | 57.54B | ||
| 40.86x | 4.23x | 7.2x | 6.3x | 20.46x | 28.26x | 0.58% | 53.75B | ||
| 49.41x | 6.66x | 1.12x | 13.07x | 28.33x | 35.52x | -.--% | 52.52B | ||
| 16.58x | 1.41x | -3.92x | 2.84x | 8.64x | 9.87x | -.--% | 25.31B | ||
| 15.42x | 3.24x | 0x | 2.95x | 9.37x | 8.99x | -.--% | 18.87B | ||
| 77.1x | 7.56x | -0.04x | 9.19x | 82.5x | 94.64x | -.--% | 18.42B | ||
| 264.33x | 58.41x | 5.45x | 94.2x | 143.1x | 145.93x | - | 16.49B | ||
| -21.13x | - | -1.09x | 30.7x | -31.09x | -30.22x | -.--% | 14.27B | ||
| -594.01x | 2.77x | 5.66x | 4.32x | 11.23x | 24.3x | -.--% | 12.4B | ||
| -3.55x | 1.34x | 0.3x | 3.06x | -1.79x | -1.7x | -.--% | 11.58B | ||
| -15.93x | - | -0.29x | 517.56x | -15.7x | -15.86x | -.--% | 10.79B | ||
| 19.09x | 1.67x | 0.7x | 2.85x | 13.17x | 13.9x | -.--% | 10.18B | ||
| 6.49x | 2.7x | 0.02x | 2.88x | 4.33x | 4.37x | 2.81% | 8.85B | ||
| -261.95x | - | 0.8x | - | - | - | -.--% | 8.45B | ||
| -39.37x | 165.67x | 1.07x | 11.79x | -48.42x | -42.79x | -.--% | 7.5B | ||
| 37.98x | - | 0.34x | 16.58x | 38.96x | 39.61x | -.--% | 7.16B | ||
| Average | -19.50x | 18.71x | 1.03x | 42.90x | 17.43x | 20.86x | 0.46% | 23.24B | |
| Weighted average by Cap. | 10.10x | 9.15x | 1.52x | 24.08x | 19.96x | 23.85x | 0.63% |
- Stock Market
- Equities
- GRF Stock
- Sector Grifols, S.A.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















